These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7940926)

  • 1. Potential for CsA-Neoral in organ transplantation.
    Levy G; Grant D
    Transplant Proc; 1994 Oct; 26(5):2932-4. PubMed ID: 7940926
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine Neoral in liver transplant recipients.
    Levy G; Rochon J; Freeman D; Wong PY; Banks L; Roach C; Engel K; Grant D
    Transplant Proc; 1994 Oct; 26(5):2949-52. PubMed ID: 7940930
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine pharmacology.
    Lee JI; Canafax DM
    Transplant Proc; 1996 Aug; 28(4):2156-8. PubMed ID: 8769185
    [No Abstract]   [Full Text] [Related]  

  • 4. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
    Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K
    Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of cyclosporine on the development of immunosuppressive therapy.
    Fritsche L; Dragun D; Neumayer HH; Budde K
    Transplant Proc; 2004 Mar; 36(2 Suppl):130S-134S. PubMed ID: 15041322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus statements on the optimal use of cyclosporine in pediatric patients.
    Brodehl J
    Transplant Proc; 1994 Oct; 26(5):2759-62. PubMed ID: 7940869
    [No Abstract]   [Full Text] [Related]  

  • 7. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine microemulsion formulation (Neoral) in transplantation: pharmacokinetic/pharmacodynamic relationships.
    Mueller EA; Niese D; Mellein B
    Transplant Proc; 1998 Aug; 30(5):1694-6. PubMed ID: 9723247
    [No Abstract]   [Full Text] [Related]  

  • 10. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L
    Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion from cyclosporine Sandimmun to cyclosporine neoral in liver transplant patients with cholestasis or external biliary drainage.
    Farges O; Haddad N; Girault D; Cabiac MD; Samuel D; Bismuth H
    Transplant Proc; 1995 Aug; 27(4):2506-7. PubMed ID: 7652905
    [No Abstract]   [Full Text] [Related]  

  • 12. Neoral C2 monitoring in solid organ transplantation.
    Levy GA
    Transplant Proc; 2004 Mar; 36(2 Suppl):392S-395S. PubMed ID: 15041373
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality assessment of cyclosporine measurements: comparison of current methods.
    Holt DW; Marsden JT; Johnston A
    Transplant Proc; 1990 Jun; 22(3):1234-9. PubMed ID: 2190385
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporin A (Neoral) in pediatric organ transplantation. Neoral Pediatric Study Group.
    Hoyer PF
    Pediatr Transplant; 1998 Feb; 2(1):35-9. PubMed ID: 10084758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoral in liver transplantation.
    Jamieson NV; Tan L; Jamieson I; Trull A; Gimson AE; Alexander G; Friend PJ; Calne RY
    Transplant Proc; 1996 Aug; 28(4):2229-31. PubMed ID: 8769207
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients.
    Schiavelli R; Sgrosso JL; Sabbatiello R; Castro C; Ahualli L; Pattin M; Vazquez MC
    Transplant Proc; 1996 Dec; 28(6):3343-4. PubMed ID: 8962299
    [No Abstract]   [Full Text] [Related]  

  • 17. Neoral/cyclosporine-based immunosuppression.
    Levy GA
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S37-47. PubMed ID: 10431016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application?
    Haller GW; Winkler M; Bechstein WO; Oldhafer KJ; Ringe B; Maibücher A; Färber L; Pichlmayr R; Neuhaus P
    Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of cyclosporine on organ transplantation.
    Margreiter R
    Transplant Proc; 1991 Aug; 23(4):2180-2. PubMed ID: 1871835
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.
    Ross H; Pflugfelder P; Haddad H; Cantarovich M; White M; Ignaszewski A; Howlett J; Vaillancourt M; Dorent R; Burton JR;
    J Heart Lung Transplant; 2008 Feb; 27(2):197-202. PubMed ID: 18267227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.